In this episode of the Clinical Research Coach, I sit down with Ella Balasa, a cystic fibrosis patient advocate whose lived experience is shaping how our industry understands trust, transparency, and meaningful patient engagement.

Diagnosed in infancy with cystic fibrosis, a progressive genetic lung disease, Ella has spent her life navigating hospital systems, breakthrough therapies, and clinical trials — not as an abstract participant, but as someone whose health and future depend on research progress. Along the way, she has become a powerful voice for improving how industry partners with patients.

In this conversation, Ella shares what sponsors, sites, and biotech leaders often overlook:

* Patient experience is never one-size-fits-all — even within the same diagnosis.

* Patients learn about trials through trusted networks, not just databases or digital ads.

* Transparency builds confidence and drives long-term participation in research.

* Dropout affects more than timelines — it influences trust and future enrollment decisions.

* Technology should support patients, but never replace human connection.

Ella’s perspective challenges us to think beyond enrollment metrics and toward something deeper: relational trust. Because sustainable progress in clinical research depends on listening to patients as individuals, partners, and experts in their own lives.

To learn more about Ella:

Https:/ellabalasa.com